Search

Your search keyword '"Infants (Premature) -- Care and treatment"' showing total 1,244 results
Start Over Descriptor "Infants (Premature) -- Care and treatment"
1,244 results on '"Infants (Premature) -- Care and treatment"'

151. Tellus Therapeutics Announces $35 Million Series A Financing

Subjects
Brain -- Injuries, Neonatal intensive care, Venture capital companies, Infants (Premature) -- Care and treatment, General interest, News, opinion and commentary
Abstract

DURHAM, N.C: TELLUS THERAPEUTICS has issued the following news release: Tellus Therapeutics, a neonatal care company developing treatments for newborns in the neonatal intensive care unit (NICU), announced today the [...]

Published
2022

152. Tellus Therapeutics Announces $35 Million Series A Financing

Subjects
Brain -- Injuries, Venture capital, Neonatal intensive care, Venture capital companies, Infants (Premature) -- Care and treatment, Venture capital, Business, Business, international
Abstract

- Funds will support development of TT-20 into clinical trials for white matter brain injury in preterm infants and Tellus pipeline program - - Financing led by the Perceptive Xontogeny [...]

Published
2022

153. Unexpectedly Early: Supporting Premature Babies & Their Families

Author

Marin, Jan

Subjects
Pregnancy, Complications of -- Evaluation -- Care and treatment, Infants (Premature) -- Care and treatment, Business, international
Abstract

Timing is everything when it comes to a pregnancy. From choosing an opportune time in your life to plan a pregnancy, to using an ovulation calendar to determine a window [...]

Published
2022

154. Bayer receives positive CHMP opinion for Eylea in the EU for treatment of preterm infants with retinopathy of prematurity

Subjects
Bayer AG, Vision disorders in children -- Care and treatment, Retrolental fibroplasia -- Care and treatment, Infants (Premature) -- Care and treatment, Pharmaceutical industry, Business, Chemicals, plastics and rubber industries, European Union. European Commission, Eylea (Medication)
Abstract

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for a label extension for Eylea (aflibercept) for intravitreal injection 40 mg/mL in a prefilled syringe (PFS) for the treatment of preterm infants with retinopathy of prematurity (ROP). The final decision from the European Commission on the label extension is expected in the coming months. Currently treatment options are limited. Conventional treatment with laser photocoagulation is associated with the destruction of retinal tissue, which may result in significant long-term complications such as high myopia (nearsightedness) and peripheral vision loss. Globally, it is estimated that each year approximately 50,000 babies born prematurely, who survive the neonatal period, develop vision-threatening ROP. In more serious cases, ROP can lead to blindness secondary to retinal detachment. Bayer will apply for a patent term extension for the European patent covering aflibercept, the active ingredient in Eylea, of six months once the European Commission adopts a decision for a label extension of Eylea. Such an extension would prolong the patent term for that patent to Nov 2025. Bayer and Regeneron are collaborating on the global development of aflibercept. Regeneron maintains exclusive rights to Eylea in the United States. Bayer has licensed the exclusive marketing rights outside the United States, where the companies share equally the profits from sales of Eylea. Original source: Bayer, website:http://www.bayer.com/, Copyright Bayer AG 2022., joint venture; patents and technical know-how; regulations and rulings; research and development; aflibercept; Eylea; Bayer; [...]

Published
2022

155. Nuwellis Announces Peer Reviewed Data Demonstrating 71% Survival with Kidney Replacement Therapy Using a Modified Aquadex in Low-Birth-Weight Preterm Neonates

Subjects
Pediatrics, Chronic kidney failure -- Care and treatment, Children -- Health aspects, Infants (Premature) -- Care and treatment, Banking, finance and accounting industries, Business
Abstract

MINNEAPOLIS, Nov. 03, 2022 (GLOBE NEWSWIRE) -- https://www.globenewswire.com/Tracker?data=Q9KXFkj2c3wL-2oXX5dqIESJgUBrhq-AvQvVYBOxwYTnfs3nz9Sss89zq8rcErXIN4PzrRmiOdKr7yay79dfAA== (NasdaqCM: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced the publication of promising [...]

Published
2022

156. Deep dive into 2023 predictions for women's health

Subjects
Mothers -- Patient outcomes, Physicians -- Beliefs, opinions and attitudes, Infants (Premature) -- Care and treatment, Market trend/market analysis, Health, Health care industry
Abstract

Alison Cowan, MD, board-certified obstetrician-gynecologist and head of medical affairs for Mirvie, discusses the latest predictions for women's health in 2023. From maternal mortality to preterm birth, Cowan dives into [...]

Published
2023

157. Investigators at NORCE Norwegian Research Centre AS Report Findings in Anxiety Disorders (Short-term Music Therapy for Families With Preterm Infants: a Randomized Trial)

Subjects
Music therapy -- Reports, Mental health -- Reports, Clinical trials -- Reports, Anxiety -- Care and treatment, Infants (Premature) -- Care and treatment, Health
Abstract

2023 APR 21 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Data detailed on Mental Health Diseases and Conditions - Anxiety Disorders have been [...]

Published
2023

158. Researcher's Work from Ain Shams University Focuses on Nephrocalcinosis (Bone mineral content for preterm neonates treated with caffeine using dual energy X-ray absorptiometry: An observational study)

Subjects
Caffeine -- Research, Infants (Premature) -- Care and treatment, Health, Ain Shams University
Abstract

2023 MAR 24 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- New research on nephrocalcinosis is the subject of a new report. According to [...]

Published
2023

159. Studies from Children's Hospital Philadelphia Have Provided New Information about Pain and Central Nervous System (Expanding Neonatal Ecmo Criteria: When Is the Premature Neonate Too Premature)

Subjects
Neonatology -- Research -- Reports -- Analysis, Infants (Premature) -- Care and treatment, Central nervous system -- Analysis -- Reports -- Research, Health
Abstract

2023 MAR 10 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Research findings on Pain and Central Nervous System are discussed in a new [...]

Published
2023

160. Reports Summarize Hormones Research from University of Cambridge (Combined Statin and Glucocorticoid Therapy for the Safer Treatment of Preterm Birth)

Subjects
Corticosteroids -- Research, Statins -- Research, Adrenocortical hormones -- Research, Hormones -- Research, Infants (Premature) -- Care and treatment, Health, University of Cambridge
Abstract

2023 FEB 24 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Data detailed on hormones have been presented. According to news reporting originating from [...]

Published
2023

161. Findings on Retinopathy of Prematurity Detailed by Investigators at Sutcu Imam University (Retinopathy of Prematurity Incidence and Treatment Modalities In Moderate and Late Preterm Infants: a Study From Two Tertiary Centers)

Subjects
Retrolental fibroplasia -- Research -- Care and treatment, Homeopathy -- Materia medica and therapeutics, Therapeutics -- Research, Neonatology -- Research, Infants (Premature) -- Care and treatment, Health
Abstract

2023 FEB 10 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Data detailed on Eye Diseases and Conditions - Retinopathy of Prematurity have been [...]

Published
2023

162. Researchers' Work from Guangzhou Women and Children's Medical Center Focuses on Glycopeptide Antibiotics (Vancomycin-lock therapy for prevention of catheter-related bloodstream infection in very low body weight infants)

Subjects
Obesity -- Care and treatment -- Prevention -- Research, Medical centers -- Research, Catheterization -- Research, Body weight -- Research, Infection -- Care and treatment -- Research -- Prevention, Vancomycin -- Research, Neonatology -- Research, Physical fitness -- Research, Infants (Premature) -- Care and treatment, Health
Abstract

2021 JAN 30 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in glycopeptide antibiotics. According to news originating from [...]

Published
2021

163. New Findings from Rutgers University - The State University of New Jersey Update Understanding of Phototherapy (Unbound Bilirubin Levels In Phototherapy-treated Preterm Infants Receiving Soy-based Lipid Emulsion)

Subjects
Bilirubin -- Research, Phototherapy -- Research, Physical fitness -- Research, Infants (Premature) -- Care and treatment, Health, Rutgers, The State University of New Jersey
Abstract

2021 JAN 16 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Fresh data on Drugs and Therapies - Phototherapy are presented in a [...]

Published
2021

164. Regeneron Receives Six Months of U.S. Pediatric Exclusivity for EYLEA(r) (aflibercept) Injection

Subjects
United States. Food and Drug Administration, Regeneron Pharmaceuticals Inc., Pediatrics, Infants (Premature) -- Care and treatment, Pharmaceutical industry, General interest, News, opinion and commentary, Eylea (Medication)
Abstract

TARRYTOWN: Regeneron Pharmaceuticals, Inc. has issued the following news release: Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the U.S. Food and Drug Administration (FDA) has granted pediatric exclusivity for EYLEA(r) [...]

Published
2022

165. EYLEA(r) (aflibercept) Injection sBLA for Treatment of Retinopathy of Prematurity (ROP) Accepted for FDA Priority Review

Subjects
United States. Food and Drug Administration, Bayer AG, Regeneron Pharmaceuticals Inc., Blindness -- Care and treatment, Retrolental fibroplasia -- Care and treatment, Infants (Premature) -- Care and treatment, General interest, News, opinion and commentary, Eylea (Medication)
Abstract

TARRYTOWN: Regeneron Pharmaceuticals, Inc. has issued the following news release: Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the [...]

Published
2022

166. Germany : Eylea approved in Japan for treatment of preterm infants with retinopathy of prematurity

Subjects
Bayer AG, Blindness -- Care and treatment, Vision disorders in children -- Care and treatment, Retrolental fibroplasia -- Care and treatment, Infants (Premature) -- Care and treatment, Pharmaceutical industry, Business, international, Eylea (Medication)
Abstract

Approval is based on the Phase III study FIREFLEYE and data from the follow-up study FIREFLEYE NEXT / Retinopathy of prematurity (ROP) can lead to severe visual impairment and blindness [...]

Published
2022

167. United States : Prenatal steroid treatment may improve survival, reduce complications for extremely preterm infants

Subjects
United States. National Institutes of Health -- Reports, United States. Eunice Kennedy Shriver National Institute of Child Health and Human Development -- Reports, Pregnant women -- Care and treatment, Infants (Premature) -- Care and treatment, Business, international
Abstract

What Steroid treatment before birth appears to improve survival and reduce complications among extremely preterm infants, according to a study funded by the National Institutes of Health. Antenatal steroid therapy, [...]

Published
2022

168. Prenatal steroid treatment may improve survival, reduce complications for extremely preterm infants

Subjects
United States. National Institutes of Health, Pregnant women -- Care and treatment, Infants (Premature) -- Care and treatment, General interest, News, opinion and commentary
Abstract

BETHESDA, Md., Sept. 27, 2022 /PRNewswire-HISPANIC PR WIRE/ -- WHAT: Steroid treatment before birth appears to improve survival and reduce complications among extremely preterm infants, according to a study funded [...]

Published
2022

169. Eylea(r) approved in Japan for treatment of preterm infants with retinopathy of prematurity

Subjects
Bayer AG, Blindness -- Care and treatment, Vision disorders in children -- Care and treatment, Retrolental fibroplasia -- Care and treatment, Infants (Premature) -- Care and treatment, Pharmaceutical industry, Business, international, Eylea (Medication)
Abstract

Leverkusen: Bayer has issued the following press release: Bayer announced today that the Ministry of Health, Labour and Welfare (MHLW) in Japan has approved Eylea(r) (aflibercept) intravitreal injection 40 mg/mL [...]

Published
2022

170. Eylea approved in Japan for treatment of preterm infants with retinopathy of prematurity

Subjects
Bayer AG, Vision disorders in children -- Care and treatment, Retrolental fibroplasia -- Care and treatment, Infants (Premature) -- Care and treatment, Pharmaceutical industry -- Comparative analysis, Business, Chemicals, plastics and rubber industries, Eylea (Medication) -- Comparative analysis
Abstract

Bayer announced on 26 Sep 2022 that the Ministry of Health, Labour and Welfare (MHLW) in Japan has approved Eylea (aflibercept) intravitreal injection 40 mg/mL for the treatment of preterm infants with retinopathy of prematurity (ROP). The positive benefit-risk profile for Eylea 0.4 mg concluded by the MHLW in Japan is based on the results from the FIREFLEYE study and follow-up data from its ongoing extension study. The findings from the FIREFLEYE study were published in the Journal of the American Medical Association. In the randomized global Phase III study FIREFLEYE, intravitreal treatment with Eylea 0.4 mg compared to laser photocoagulation in patients with retinopathy of prematurity was shown to be efficacious, safe and well tolerated. 85.5% of patients receiving Eylea 0.4 mg showed absence of active ROP and unfavourable structural outcomes at 24 weeks, compared to 82.1% of patients with laser photocoagulation. Although non-inferiority could not be formally demonstrated the results are considered favourable in the context of previously existing data. Follow-up data from the ongoing Phase IIIb long-term extension study FIREFLEYE NEXT indicate that treatment outcomes are well sustained. Eylea is marketed by Santen Pharmaceutical in Japan, and Bayer is marketing authorization holder. Bayer and Regeneron are collaborating on the global development of aflibercept. Regeneron maintains exclusive rights to Eylea in the United States. Bayer has licensed the exclusive marketing rights outside the United States, where the companies share equally the profits from sales of Eylea. Original source: Bayer, website:http://www.bayer.com/, Copyright Bayer AG 2022., joint venture; patents and technical know-how; regulations and rulings; research and development; aflibercept; Eylea; Bayer; Regeneron; Santen [...]

Published
2022

171. PRENATAL STEROID TREATMENT MAY IMPROVE SURVIVAL, REDUCE COMPLICATIONS FOR EXTREMELY PRETERM INFANTS

Subjects
United States. National Institutes of Health -- Reports, United States. Eunice Kennedy Shriver National Institute of Child Health and Human Development -- Reports, Pregnant women -- Care and treatment, Infants (Premature) -- Care and treatment, News, opinion and commentary
Abstract

BETHESDA, Md. -- The following information was released by the National Institutes of Health: What Steroid treatment before birth appears to improve survival and reduce complications among extremely preterm infants, [...]

Published
2022

172. Prolacta Bioscience Recognizes Nurses Caring for Fragile Infants Every Day Throughout Neonatal Nurses Week and NICU Awareness Month

Subjects
Biotechnology industry, Neonatal intensive care, Infants (Premature) -- Care and treatment, Nurses, General interest, News, opinion and commentary
Abstract

DUARTE: Prolacta Bioscience has issued the following news release: Prolacta Bioscience(r), the world's leading hospital provider of 100% human milk-based nutritional products for critically ill, premature infants, is celebrating National [...]

Published
2022

173. Special blankets provide phototherapy at home for premature babies

Subjects
Phototherapy, Charities, Infants (Premature) -- Care and treatment, Business, Business, international
Abstract

M2 PRESSWIRE-July 18, 2022-: Special blankets provide phototherapy at home for premature babies (C)1994-2022 M2 COMMUNICATIONS RDATE:18072022 When babies are born prematurely it goes without saying that they require specialist [...]

Published
2022

174. NICE RECOMMENDS POTENTIALLY LIFE-CHANGING TREATMENT FOR PEOPLE WITH SHORT BOWEL SYNDROME

Subjects
Malabsorption syndromes -- Care and treatment, Infants (Premature) -- Care and treatment, News, opinion and commentary
Abstract

LONDON -- The following information was released by the National Institute for Health and Clinical Excellence (UK): A potentially life-changing treatment has been recommended for people with short bowel syndrome [...]

Published
2022

175. Medical advances saving premature babies pose thorny issues for abortion rights advocates

Author

Cha, Ariana Eunjung

Subjects
United States. Supreme Court -- Powers and duties, Neonatology -- Innovations, Abortion -- Laws, regulations and rules, Infants (Premature) -- Care and treatment, Government regulation, General interest, News, opinion and commentary
Abstract

Byline: Ariana Eunjung Cha The clock struck midnight as Kourtney Vier was wheeled into the delivery room at the University of Iowa Hospital. She had just crossed the line between [...]

Published
2021

176. Tellus Therapeutics Closes $35 Million Series A financing Round

Subjects
Brain -- Injuries, Neonatal intensive care, Venture capital companies -- Finance, Infants (Premature) -- Care and treatment, Company financing, Business, Business, international, Telecommunications industry
Abstract

Tellus Therapeutics, a neonatal care company developing treatments for newborns in the neonatal intensive care unit (NICU), recently reported the closing of a Series A financing round of $35 million [...]

Published
2023

177. Mindfulness-Based Cognitive Therapy in Pregnancy and Sleep Quality: Secondary Analysis from a Randomized Controlled Trial (Updated December 8, 2022)

Subjects
Medical research -- Analysis, Medicine, Experimental -- Analysis, Cognitive therapy -- Analysis, Clinical trials -- Analysis, Sleep disorders -- Care and treatment, Pregnant women -- Care and treatment, Evidence-based medicine -- Analysis, Infants (Premature) -- Care and treatment, Health
Abstract

2022 DEC 30 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- According to news reporting based on a preprint abstract, our journalists obtained the [...]

Published
2022

178. New Apnea of Prematurity Study Findings Have Been Reported from Children's Hospital of Nanjing Medical University (Precision caffeine therapy for apnea of prematurity and circadian rhythms: New possibilities open up)

Subjects
Caffeine -- Research, Hallucinogenic drugs -- Research, Neonatology -- Research -- Reports, Apnea -- Care and treatment -- Research, Infants (Premature) -- Care and treatment, Health
Abstract

2022 DEC 19 (NewsRx) -- By a News Reporter-Staff News Editor at Respiratory Therapeutics Week -- New study results on apnea of prematurity have been published. According to news reporting [...]

Published
2022

179. Tellus Therapeutics Raises USD 35m in Series A Financing

Subjects
Brain -- Injuries, Venture capital, Venture capital companies -- Finance, Infants (Premature) -- Care and treatment, Company financing, Venture capital, Chemistry
Abstract

M2 PHARMA-December 16, 2022-Tellus Therapeutics Raises USD 35m in Series A Financing (C)2022 M2 COMMUNICATIONS - US-based neonatal care company Tellus Therapeutics has closed a series A financing round of [...]

Published
2022

180. Investigators from Guangdong Provincial People's Hospital Report New Data on Congenital Heart Disease (The Implications of an Integrated Management Model of Prenatal Diagnosis/postnatal Treatment for Premature Infants With Critical Congenital ...)

Subjects
Heart diseases -- Care and treatment -- Research, Congenital heart disease -- Research -- Care and treatment, Medical research -- Analysis -- Reports, Medicine, Experimental -- Analysis -- Reports, Genetic disorders -- Research -- Care and treatment, Pregnant women -- Care and treatment, Infants (Premature) -- Care and treatment, Company business management, Health
Abstract

2022 DEC 16 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Fresh data on Congenital Diseases and Conditions - Congenital Heart Disease are presented [...]

Published
2022

181. Study Findings on Diet and Nutrition Published by Researchers at Reina Sofia University Hospital (Impact of Total Parenteral Nutrition on Gut Microbiota in Pediatric Population Suffering Intestinal Disorders)

Subjects
Microbiota (Symbiotic organisms) -- Research, Nutrition -- Research, Gastrointestinal diseases -- Research -- Care and treatment, Infants (Premature) -- Care and treatment, Diet -- Research, Health
Abstract

2022 DEC 2 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators discuss new findings in diet and nutrition. According to news reporting out [...]

Published
2022

182. Researcher at Duke University Publishes Research in Premature Birth (Insulin for treatment of neonatal hyperglycemia in premature infants : Prevalence over time and association with outcomes)

Subjects
Diabetes therapy -- Research, Insulin -- Research, Premature birth -- Research -- Care and treatment, Neonatal intensive care -- Research, Hyperglycemia -- Research -- Care and treatment, Infants (Premature) -- Care and treatment, Health, Duke University
Abstract

2022 DEC 2 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on premature birth. According to news reporting originating from [...]

Published
2022

183. A mom died of covid-19 before making a baby registry. A nurse - and strangers - pitched in

Author

Kornfield, Meryl

Subjects
Epidemics -- Social aspects -- United States, Fund raising -- Methods, Infants' supplies -- Finance, Infants -- Equipment and supplies, Infants (Premature) -- Care and treatment, Nurses -- Appreciation, Company financing, General interest, News, opinion and commentary
Abstract

Byline: Meryl Kornfield Ashlee Schwartz noticed 23-year-old Eric Robison looking heartbroken, peering through the glass into his wife Emily's hospital room. The nurse thought about the couple's baby, born prematurely [...]

Published
2021

184. Boosting micropreemie outcomes

Author

Hilton, Lisette

Subjects
Infants -- Care and treatment, Evidence-based medicine, Infants (Premature) -- Care and treatment, Health, Health care industry, Children's Hospital of Orange County -- Services
Abstract

Hospital-based care for extremely low-birth-weight (ELBW) infants has evolved significantly, resulting in improved outcomes at discharge. One children's hospital pushes its care of ELBW infants even further to reduce high-risk [...]

Published
2016

185. Blood test to diagnose pre-eclampsia to be offered on NHS for first time; Breakthrough could allow for speedy treatment of condition which can affect pregnant women, and could reduce number of preterm babies born

Subjects
Blood -- Medical examination, Preeclampsia -- Care and treatment, Pregnant women -- Care and treatment, Infants (Premature) -- Care and treatment, Hypertension -- Care and treatment, General interest, News, opinion and commentary
Abstract

Byline: Lizzie Roberts, Health Reporter A blood test that can diagnose pre-eclampsia will be offered on the NHS for the first time. Pre-eclampsia affects some pregnant women, usually during the [...]

Published
2022

186. RESEARCHERS IDENTIFY POTENTIAL APPROACHES TO MODIFY THE VAGINAL MICROBIOME

Subjects
Infants (Premature) -- Care and treatment, News, opinion and commentary, Harvard University. Harvard Medical School, Massachusetts General Hospital
Abstract

BOSTON, MA -- The following information was released by the Massachusetts General Hospital (MGH): The female genital tract is naturally colonized by mixed communities of bacteria, known as the vaginal [...]

Published
2022

187. Oak Hill Bio Launches With Pipeline and Senior Leadership From Takeda

Subjects
Takeda Pharmaceutical Company Ltd. -- Contracts -- Product development, Autoimmune diseases -- Care and treatment, Infants (Premature) -- Care and treatment, Pharmaceutical industry -- Contracts -- Product development, Contract agreement, Business, Business, international
Abstract

New Company Committed to Developing Life-Changing Medicines for Extremely Preterm Infants and Patients Suffering from Rare Autoimmune Diseases Pipeline Includes Two Programs with Phase 2 Proof-of-Concept Data in Rare Diseases [...]

Published
2022

188. Department of Pediatrics Researcher Describes Research in Respiratory Distress Syndrome (Profound Effect of Pulmonary Surfactant on the Treatment of Preterm Infants with Respiratory Distress Syndrome)

Subjects
Medical research, Medicine, Experimental, Pediatrics -- Research, Respiratory distress syndrome -- Research -- Care and treatment, Surface active agents -- Research, Infants (Premature) -- Care and treatment, Pediatric respiratory diseases -- Research -- Care and treatment, Health
Abstract

2022 OCT 17 (NewsRx) -- By a News Reporter-Staff News Editor at Respiratory Therapeutics Week -- A new study on respiratory distress syndrome is now available. According to news reporting [...]

Published
2022

189. Airway Therapeutics doses first patient in zelpultide alfa (rhSP-D) Phase 1b trial

Subjects
Medicine, Preventive, Clinical trials, Preventive health services, Infants (Premature) -- Care and treatment, Chemistry
Abstract

M2 PHARMA-October 4, 2022-Airway Therapeutics doses first patient in zelpultide alfa (rhSP-D) Phase 1b trial (C)2022 M2 COMMUNICATIONS Airway Therapeutics, Inc., a US-based biopharmaceutical company, announced on Monday that it [...]

Published
2022

190. Airway Therapeutics doses first patient in zelpultide alfa (rhSP-D) Phase 1b trial

Subjects
Medicine, Preventive, Clinical trials, Preventive health services, Infants (Premature) -- Care and treatment, Business
Abstract

M2 EQUITYBITES-October 4, 2022-Airway Therapeutics doses first patient in zelpultide alfa (rhSP-D) Phase 1b trial (C)2022 M2 COMMUNICATIONS http://www.m2.com Airway Therapeutics, Inc., a US-based biopharmaceutical company, announced on Monday that [...]

Published
2022

191. Researcher from Bahraich Provides Details of New Studies and Findings in the Area of Neonatal Hyperbilirubinemia (Electrolyte Changes in Neonates Before And After Phototherapy For Neonatal Hyperbilirubinemia: A Prospective Hospital-based ...)

Subjects
Electrolytes -- Research, Phototherapy -- Research, Neonatal intensive care -- Research, Neonatal jaundice -- Research -- Care and treatment, Infants (Premature) -- Care and treatment, Health
Abstract

2022 SEP 5 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- Investigators discuss new findings in neonatal hyperbilirubinemia. According to news reporting from Bahraich, India, by [...]

Published
2022

192. Findings on Medical Devices and Surgical Technology Reported by Investigators at Women and Children's Hospital [Management of an Incompetent Mid-second (Mid-2nd) Trimester Absent Ecto-cervix: a Case Series. Cervical Amplification Pre-cerclage ...]

Subjects
Medical equipment -- Research, Children's furniture -- Research, Physiological apparatus -- Research, Infants (Premature) -- Care and treatment, Company business management, Health, Health care industry
Abstract

2022 AUG 21 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- Fresh data on Medical Devices and Surgical Technology are presented in [...]

Published
2022

193. Study Results from Jiangnan University Broaden Understanding of Bronchopulmonary Dysplasia (Effects of Antioxidants in Human Milk on Bronchopulmonary Dysplasia Prevention and Treatment: A Review)

Subjects
Milk -- Research, Bronchopulmonary dysplasia -- Prevention -- Care and treatment -- Research, Antioxidants -- Research, Neonatology -- Research, Infants (Premature) -- Care and treatment, Health
Abstract

2022 AUG 5 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Data detailed on bronchopulmonary dysplasia have been presented. According to news reporting out [...]

Published
2022

194. New Respiratory Therapeutics Study Findings Reported from Mount Sinai Hospital (Clinical Burden Associated With Therapies for Cardio-pulmonary Critical Decompensation In Preterm Neonates Across Canadian Neonatal Intensive Care Units)

Subjects
Mortality -- Ontario -- Canada, Nitric oxide -- Reports -- Research, Neonatal intensive care -- Research -- Reports, Infants (Premature) -- Care and treatment, Health, Mount Sinai Hospital -- Reports
Abstract

2022 AUG 5 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on Respiratory Therapeutics. According to news reporting originating in [...]

Published
2022

195. Data on Sepsis Reported by Researchers at Shandong University (Clinical Significance of Mir-129-5p In Patients With Neonatal Sepsis and Its Regulatory Role In the Lipopolysaccharide-induced Inflammatory Response)

Subjects
Medical research, Medicine, Experimental, Infection -- Care and treatment -- Research, Infants (Premature) -- Care and treatment, Health
Abstract

2022 AUG 5 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- A new study on Blood Diseases and Conditions - Sepsis is now available. [...]

Published
2022

196. Which ELGANs are most at risk of low lung function?

Author

Freedman, Marian

Subjects
Neonatal intensive care -- Methods, Pediatric research, Gestational age -- Health aspects, Infants (Premature) -- Care and treatment, Health, Health care industry
Abstract

In extremely low gestational age newborns (ELGANs), certain demographic factors and less-than-optimal respiratory support in or beyond the neonatal intensive care unit (NICU) can increase the risk of abnormal lung [...]

Published
2022

197. Blaine Labs Issues Voluntary Nationwide Recall of RevitaDerm Wound Care Gel Due to Bacterial Contamination

Subjects
Product recalls -- Health aspects, Infants (Premature) -- Care and treatment, Wounds and injuries -- Care and treatment, Product recall, General interest, News, opinion and commentary
Abstract

SANTA FE SPRINGS: Blaine Labs Inc has issued the following news release: Blaine Labs Company is voluntarily recalling one lot of RevitaDerm Wound Care to the consumer level because a [...]

Published
2022

198. Blaine Labs Issues Voluntary Nationwide Recall of RevitaDerm Wound Care Gel Due to Bacterial Contamination

Subjects
Product recalls -- Health aspects, Infants (Premature) -- Care and treatment, Wounds and injuries -- Care and treatment, Product recall, Business, News, opinion and commentary
Abstract

SANTA FE SPRINGS, Calif., Jan. 27, 2022 /PRNewswire/ -- Blaine Labs Company is voluntarily recalling one lot of RevitaDerm Wound Care to the consumer level because a bottle of the [...]

Published
2022

199. Adding a Single Key Gut Bacterium, B. infantis EVC001 to Human Milk Feeding Protocols May Help in the Managed Care of Very Low Birth Weight Infants

Subjects
Bifidobacterium -- Dosage and administration -- Influence, Infants (Premature) -- Care and treatment, Business, Business, international, Oregon Health & Science University -- Research -- Reports
Abstract

Study Published in Journal of Pediatrics Discusses Potential for Improved Clinical Care Associated with Administration of B. infantis EVC001 in Very Low Birth Weight Infants DAVIS, Calif. -- Research published [...]

Published
2022

200. Aerogen Pharma Enters into Exclusive Agreements with Nuance Pharma to Advance Treatment of Respiratory Distress Syndrome in Premature Infants in China

Subjects
Respiratory distress syndrome -- Care and treatment, Respiratory agents, Neonatology, Infants (Premature) -- Care and treatment, Company licensing agreement, Business, News, opinion and commentary
Abstract

The license agreement provides Nuance Pharma exclusive rights to develop and commercialize AeroFact for treatment of Respiratory Distress Syndrome (RDS) in all of Greater China. Aerogen Pharma will receive upfront [...]

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results